chr11-47337564-C-T

Variant summary

Our verdict is . The variant received 9 ACMG points: 9P and 0B. PS3PM1PM5PP5

The NM_000256.3(MYBPC3):​c.2429G>A​(p.Arg810His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000719 in 1,613,846 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). ClinVar reports functional evidence for this variant: "SCV005399174: "Functional evidence for this variant is inconclusive. In a functional study using rat ventricular myocytes, the variant was not shown to impact myofilament assembly similar to pathogenic variants in the C10 domain, however it did show a significantly increased protein half-life compared to wild type. The authors concluded that further work is required to elucidate the pathogenic mechanism of variants located in the C3 and C6 domains (PMID:32841044)."" and additional evidence is available in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R810L) has been classified as Likely pathogenic. The gene MYBPC3 is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.000053 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000074 ( 0 hom. )

Consequence

MYBPC3
NM_000256.3 missense

Scores

12
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:14U:4

Conservation

PhyloP100: 7.57

Publications

31 publications found
Variant links:
Genes affected
MYBPC3 (HGNC:7551): (myosin binding protein C3) MYBPC3 encodes the cardiac isoform of myosin-binding protein C. Myosin-binding protein C is a myosin-associated protein found in the cross-bridge-bearing zone (C region) of A bands in striated muscle. MYBPC3 is expressed exclusively in heart muscle and is a key regulator of cardiac contraction. Mutations in this gene are a frequent cause of familial hypertrophic cardiomyopathy. [provided by RefSeq, May 2022]
MYBPC3 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • left ventricular noncompaction 10
    Inheritance: AD, AR Classification: DEFINITIVE, MODERATE, LIMITED Submitted by: Ambry Genetics
  • hypertrophic cardiomyopathy 4
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • atrial fibrillation
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • congenital heart disease
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • dilated cardiomyopathy
    Inheritance: AD, AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000256.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 9 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV005399174: "Functional evidence for this variant is inconclusive. In a functional study using rat ventricular myocytes, the variant was not shown to impact myofilament assembly similar to pathogenic variants in the C10 domain, however it did show a significantly increased protein half-life compared to wild type. The authors concluded that further work is required to elucidate the pathogenic mechanism of variants located in the C3 and C6 domains (PMID: 32841044)."; SCV005429968: "A functional study has shown that this variant had a 44% prolonged MyBPC protein half-life compared to wild-type (PMID: 32841044)."; SCV001350552: "A functional study has shown that this variant had a 44% prolonged MyBPC protein half-life compared to wild-type (PMID: 32841044)."
PM1
In a hotspot region, there are 4 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 26 uncertain in NM_000256.3
PM5
Other missense variant is known to change same aminoacid residue: Variant chr11-47337564-C-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 181127.
PP5
Variant 11-47337564-C-T is Pathogenic according to our data. Variant chr11-47337564-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 42620.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000256.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYBPC3
NM_000256.3
MANE Select
c.2429G>Ap.Arg810His
missense
Exon 25 of 35NP_000247.2Q14896-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYBPC3
ENST00000545968.6
TSL:5 MANE Select
c.2429G>Ap.Arg810His
missense
Exon 25 of 35ENSP00000442795.1Q14896-1
MYBPC3
ENST00000399249.6
TSL:5
c.2429G>Ap.Arg810His
missense
Exon 24 of 34ENSP00000382193.2A8MXZ9
MYBPC3
ENST00000544791.1
TSL:5
n.2414-53G>A
intron
N/AENSP00000444259.1F5GZR4

Frequencies

GnomAD3 genomes
AF:
0.0000526
AC:
8
AN:
152184
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000482
AC:
12
AN:
249184
AF XY:
0.0000666
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000290
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000974
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000739
AC:
108
AN:
1461662
Hom.:
0
Cov.:
33
AF XY:
0.0000825
AC XY:
60
AN XY:
727108
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.0000224
AC:
1
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86252
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53378
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000935
AC:
104
AN:
1111860
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000526
AC:
8
AN:
152184
Hom.:
0
Cov.:
31
AF XY:
0.0000942
AC XY:
7
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41460
American (AMR)
AF:
0.00
AC:
0
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68034
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000226
Hom.:
0
Bravo
AF:
0.0000604
EpiCase
AF:
0.000109
EpiControl
AF:
0.000356

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
5
-
-
Hypertrophic cardiomyopathy (5)
3
2
-
not provided (5)
2
-
-
Cardiomyopathy (2)
2
-
-
Hypertrophic cardiomyopathy 4 (2)
1
-
-
Cardiovascular phenotype (1)
1
-
-
Hypertrophic cardiomyopathy 4;C3715165:Left ventricular noncompaction 10 (1)
-
1
-
not specified (1)
-
1
-
Primary familial hypertrophic cardiomyopathy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.65
CardioboostCm
Pathogenic
0.98
BayesDel_addAF
Pathogenic
0.19
D
BayesDel_noAF
Pathogenic
0.24
CADD
Pathogenic
30
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.46
T
Eigen
Pathogenic
0.81
Eigen_PC
Pathogenic
0.75
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Pathogenic
1.0
D
M_CAP
Uncertain
0.26
D
MetaRNN
Pathogenic
0.85
D
MetaSVM
Uncertain
-0.18
T
MutationAssessor
Pathogenic
3.1
M
PhyloP100
7.6
PrimateAI
Uncertain
0.72
T
PROVEAN
Pathogenic
-4.6
D
REVEL
Uncertain
0.62
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.0020
D
Varity_R
0.71
gMVP
0.75
Mutation Taster
=3/97
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.